Thomas K. Equels
2017
In 2017, Thomas K. Equels earned a total compensation of $987.2K as CEO & President at Hemispherx Biopharma, a 26% increase compared to previous year.
Compensation breakdown
| Bonus | $22,067 |
|---|---|
| Option Awards | $174,052 |
| Salary | $712,500 |
| Other | $78,604 |
| Total | $987,223 |
Equels received $712.5K in salary, accounting for 72% of the total pay in 2017.
Equels also received $22.1K in bonus, $174.1K in option awards and $78.6K in other compensation.
Rankings
In 2017, Thomas K. Equels' compensation ranked 9,042nd out of 14,666 executives tracked by ExecPay. In other words, Equels earned more than 38.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,042 out of 14,666 | 38th |
Division Manufacturing | 3,455 out of 5,768 | 40th |
Major group Chemicals And Allied Products | 1,182 out of 2,074 | 43rd |
Industry group Drugs | 945 out of 1,730 | 45th |
Industry Biological Products, Except Diagnostic Substances | 171 out of 316 | 46th |
Source: SEC filing on August 3, 2018.
Equels' colleagues
We found two more compensation records of executives who worked with Thomas K. Equels at Hemispherx Biopharma in 2017.